Clinical Trial Update: Description of Joint Population and Assessment of Impact on Health Status of Orencia in Patients With Rheumatoid Arthritis in France. A Database Analysis Based on SFR's ORA Long-term Cohort Study

View source ↗

Summary

The document notes the withdrawal of the NCT01694693 study evaluating abatacept (Orencia) in rheumatoid arthritis patients in France. It describes the planned j…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• ORENCIA (ABATACEPT)

Snippet

Sponsor: Bristol-Myers Squibb | Conditions: Rheumatoid Arthritis | Status: WITHDRAWN